Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Teicoplanin Administration Guidelines

Introduction to Teicoplanin Dilution

  • Teicoplanin can be diluted in normal saline (0.9% sodium chloride) as indicated by guidelines from the Journal of Microbiology, Immunology and Infection 1
  • Crystalloids like saline solutions are appropriate for diluting many antibiotics, including glycopeptides like teicoplanin, according to the Journal of Allergy and Clinical Immunology 3

Administration and Dosing

  • Teicoplanin is typically administered as an intravenous infusion after proper dilution, with a standard dosing regimen consisting of a loading dose of 12 mg/kg every 12 hours for three doses, followed by a maintenance dose of 6-12 mg/kg once daily 2
  • For severe infections such as endocarditis, septic arthritis, osteomyelitis, and complicated bacteremia, a higher maintenance dose of 12 mg/kg daily is recommended 2

Dosing Adjustments for Renal Function

  • For patients with normal renal function, a dose of 6-12 mg/kg every 24 hours is recommended 4
  • For patients with moderate renal impairment (GFR 10-50 mL/min), a dose of 6-12 mg/kg every 48 hours is recommended 4
  • For patients with severe renal impairment (GFR <10 mL/min), a dose of 6-12 mg/kg every 72 hours is recommended 4
  • For hemodialysis patients, a loading dose of 12 mg/kg, followed by 6 mg/kg on days 2 and 3, and maintenance of 6 mg/kg once weekly is recommended 4

Therapeutic Monitoring and Pitfalls

  • For severe infections like endocarditis or septic arthritis, target trough concentrations of at least 20 mg/L are recommended 2, 4
  • Therapeutic drug monitoring is recommended for severe infections to ensure adequate dosing 2, 4
  • Regular monitoring of renal function is recommended, especially in patients receiving prolonged therapy or concomitant nephrotoxic medications 2
  • Failure to provide adequate loading doses can lead to inadequate therapeutic levels, regardless of renal function 4
  • Not extending dosing intervals appropriately in renal impairment can lead to drug accumulation 4
  • Overlooking the need for therapeutic drug monitoring in high-risk situations or specific infections can lead to suboptimal outcomes 4

REFERENCES

3

Teicoplanin Dosing Guidelines for Adults [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Teicoplanin Dosing in Patients with Impaired Renal Function [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025